By Partha Ghosh, MD, Siemens Healthineers
Clinical impact of absolute SPECT/CT quantification in theranostics and dosimetry
24.06.2020
Major advances in SPECT/CT technology have enabled absolute quantification to be accurate and reproducible. Download the white paper and explore the clinical impact of SPECT/CT quantification in theranostics and dosimetry.
White paper
By Munir Ghesani, MD, FACNM, FACR, New York, NY, USA.
04.04.2019
PET/CT plays an increasingly important role in the appropriate clinical setting in both initial and subsequent treatment strategies in melanoma management. Read the white paper to discover the value PET/CT imaging can have for melanoma.
02.05.2018
Skeletal scintigraphy has been a mainstay of nuclear medicine for decades. Take a closer look at clinical examples that illustrate the image quality levels in bone scintigraphy made possible using xSPECT Bone™ technology in this SPECT/CT clinical white paper.
By A. Hans Vija, PhD; Carl von Gall, MD; and Partha Ghosh, MD, Siemens Healthineers
03.01.2018
The introduction of xSPECT Quant™ for absolute quantification of 177Lu, 111In, and 123I is a major step toward implementation and expansion of standardized evidence-based medicine in the realm of radionuclide imaging. Download the white paper to learn more about Siemens Healthineers’ xSPECT Quant technology.
By A. Hans Vija, PhD, Siemens Healthineers
30.09.2017
In 2013, Siemens introduced xSPECT™, which represents a more complete integration of SPECT and CT data. Download the white paper to understand the fundamentals of xSPECT reconstruction for SPECT/CT and its advantages over traditional approaches.
By Jackson Kiser, MD, Molecular Imaging and Therapy Consultants of Virginia
21.04.2016
Discover how transitioning from a mobile PET scanner—an ideal way to introduce technology to facilities interested in exploring the potential for PET imaging— to a fixed scanner can benefit in a hospital setting.
By Partha Ghosh, MD, Siemens Healthineers; and Dimitre Hristov, PhD, Department of Radiation Oncology, Stanford University
02.10.2015
Learn how PET/CT provides metabolic and morphological information, which has a major impact on the evaluation and therapy planning of primary and recurrent lung tumors.
By Kristin Schmiedehausen, MD
02.01.2015
PET/CT is a powerful modality used to assess cervical cancer, particularly in tumors of stage IB and beyond. As the topic of cervical cancer and PET/CT has been increasing in interest in the last years, stay informed on the status of the disease, guidelines, and reimbursement opportunities by reading the following white paper.
PET/CT plays an increasing role in breast cancer staging, treatment, and follow-up. Discover how new technical developments in PET scanner technologies might additional contribute to strengthening and expanding the role of clinical PET/CT in breast cancer care.
Uncover how to ensure optimal patient management and learn how the relationship between the imaging and referring physician can help to ensure optimal patient management and benefit patients by having a more personal interaction before and after a PET/CT exam.
Explore the role of PET/CT in imaging high-risk patients (such as those with an elevated PSA level or Gleason score) for skeletal metastases. Read the white paper to review PET's role on therapy decisions during initial diagnosis and therapy monitoring.
